2Pablo Iribarren,Ye Zhou,Jinyue Hu,Yingying Le,Ji Ming Wang.Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in alzheimer disease[J].Immunologic Research.2005(3)
3U. Sch?nbeck*RID="*"ID="*" Corresponding author.,P. Libby.The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review[J].Cellular and Molecular Life Sciences.2001(1)
4Tan J,Town T,Crawford F, et al.Role of CD40 ligand in amyloidosis in transgenic Alzheimer‘s mice[].National Neuroscience.2002
5Nguyen VT,Benveniste EN.Critical role of tumor necrosis factor-a and NF-κB in interferon-γ-induced CD40 expression in microglia/macrophages[].Journal of Biological Chemistry.2002
6Kielian T.Microglia and chemokines in infectious diseases of the nervous system: views and reviews[].Frontiers in Bioscience.2004
7Cui Y,Le Y,Yazawa H,Gong W,Wang JM.Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer‘s disease[].Journal of Leukocyte Biology.2002
8Aloisi F,Ambrosini E,Columba-Cabezas S,Magliozzi R,Serafini B.Intracerebral regulation of immune responses[].Annals of Medicine.2001
9Bishop GA,Hostager BS.The CD40-CD154 interaction in B cell-T cell liaisons[].Cytokine and Growth Factor Reviews.2003
10Geldart T,Illidge T.Anti-CD40 monoclonal antibody[].Leukemia and Lymphoma.2005
7Deckelbaum LI,Sax FL, Grossman W. Tirofiban, a nonpeptide inhibit or of the platelet glycoprotein Ⅱ b/Ⅲa receptors//Sasahara AA, Loscalzo J. New therapeutic agents in thrombosis and thrombolysis. New York:Marcel Dekker, 1997:355-365.
